Eurofarma and Novo Nordisk team up to fight the slimming pen war.
The patent for semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy slimming pens, expired in Brazil…
Emcure halves price of its semaglutide weight loss drug Poviztra after Novo Nordisk patent expiry — check new rates
Emcure Pharmaceuticals on Thursday announced that it has halved the price of its weight management drug Poviztra, a…